Unveiling the Hidden Dangers of Delirium in Heart Patients: A Call for Action
The Silent Threat of Delirium in Cardiovascular Care
Delirium, a sudden and acute confusion, is a silent threat often overlooked in cardiovascular care. It affects older patients who have undergone cardiac surgery or interventional procedures, and its impact goes far beyond temporary confusion. A new international review involving leading cardiologists, cardiac surgeons, intensive care physicians, and psychiatrists has revealed alarming findings: delirium is associated with longer hospital stays, increased mortality, higher rates of care dependency, and a significantly increased risk of permanent cognitive impairment. Moreover, it is an independent predictor of long-term mental decline, even in individuals who were previously cognitively normal.
The High Incidence of Delirium: Massive Consequences
A significant number of patients develop delirium, especially after complex cardiac surgery and interventional procedures such as TAVR or PCI. Despite this, delirium is often overlooked and rarely systematically recorded. The so-called hypoactive form, characterized by apathy, reduced activity, and listlessness, is often undiagnosed and mistaken for age-related or exhaustion.
Prevention is Crucial: A Multimodal Approach
The review highlights that the most effective strategy against delirium is prevention. Multimodal, non-pharmacological measures, including early mobilization, reorientation, sleep hygiene, cognitive stimulation, adequate pain management, and the involvement of relatives, can reduce the incidence of delirium by up to 40 percent. However, the study takes a critical view of the routine prophylactic use of medication.
Treatment of Delirium: Evidence-Based and Practical
The focus of treatment remains on non-pharmacological measures, which form the therapeutic basis for all degrees of severity. Pharmacological options are presented in a differentiated manner when clinically necessary. In intensive care medicine, the sedative dexmedetomidine has been shown to be beneficial in moderate to severe delirium. Antipsychotic substances can be used depending on the situation and symptoms, with careful consideration of benefits and potential cardiac side effects.
A Holistic View is Essential
A structured, step-by-step approach is crucial for delirium prevention and treatment. Early detection and interdisciplinary treatment are key to successful outcomes. Despite growing knowledge, evidence specifically for cardiovascular patient groups remains limited. The authors call for targeted, prospective studies to develop specific guidelines for prevention and treatment.
A Call for Action
Delirium prevention must become an integral part of cardiovascular care. By recognizing and addressing this silent threat, we can improve patient outcomes and reduce the risk of long-term cognitive impairment. Join the conversation and share your thoughts on how we can best prevent and treat delirium in heart patients.
